It's time to bone up on your bone health – a £200 bone scan is a sound investment to help future-proof your health, says our deputy editor ...
A randomized phase II study of cediranib (CED) alone versus CED plus dasatinib (DAS) in patients (pts) with castration-resistant prostate cancer (CRPC). Phase II trial of intravenous carboplatin (C), ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果